Perrigo Company plc PRGO

NYS: PRGO | ISIN: IE00BGH1M568 26/04/2024

31,94 USD (+2,14%)

(+2,14%) 26/04/2024

Grafiek Perrigo Company plc

Grafiek Perrigo Company plc

1 dag1d 2,14%
1 week1w 6,25%
1 maand1m -0,78%
3 maanden3m -3,71%
6 maanden6m 17,82%
1 jaar1j -14,12%
5 jaar5j -37,87%

dinsdag 7 mei 2024, 12:30

Kwartaalcijfers (1ste kwartaal)

Perrigo Company plc in het nieuws

Toon enkel gratis nieuws

25 april 2024 · Perrigo Receives Binding Offer to Divest its HRA Pharma Rare Diseases Business for up to €275 Million · Persbericht

23 april 2024 · Perrigo to Release First Quarter 2024 Financial Results on May 7, 2024 · Persbericht

9 april 2024 · Opill and WNBA Team Up for Groundbreaking Partnership · Persbericht

4 maart 2024 · Perrigo Commences Shipments of Opill® to Retailers Nationwide, Empowering Millions to Enter a New Era of Reproductive Health Access in the United States · Persbericht

29 februari 2024 · Perrigo to Attend UBS Global Consumer and Retail Conference · Persbericht

27 februari 2024 · Perrigo Reports Fourth Quarter & Fiscal Year 2023 Financial Results From Continuing Operations; Launches Investment & Efficiency Program · Persbericht

26 februari 2024 · Perrigo Increases its Quarterly Dividend · Persbericht

13 februari 2024 · Perrigo to Release Fourth Quarter and Fiscal Year 2023 Financial Results on February 27, 2024 · Persbericht

10 november 2023 · Perrigo Announces Cash Tender Offer for Notes · Persbericht

7 november 2023 · Perrigo Reports Third Quarter Fiscal Year 2023 Financial Results From Continuing Operations · Persbericht

Profiel Perrigo Company plc

Fabricage van farmaceutische preparaten

Farmaceutische producten: Andere

Gezondheidstechnologie

CEO: Murray Kessler

Werknemers: 5.210

Aandelen Perrigo Company plc

Beurswaarde: 4,33 miljard USD

Effecten: 135,52 miljoen

Winst per aandeel (12 maand): PLUS

Beta: 0,68

Mijn selecties

Je selectie is nog leeg.

Voeg nu effecten toe